Orthofix Medical (OFIX) Net Margin (2010 - 2026)

Orthofix Medical has disclosed Net Margin across 17 years of filings, most recently posting 11.23% for Q1 2026.

• Quarterly Net Margin rose 1800.0% year-over-year to 11.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.2% (up 2352.0% YoY) and the FY2025 annual result came in at 0.13%, up 1698.0% from the prior year.
• Net Margin declined to 11.23% in Q1 2026, from 41.4% in the prior quarter.
• Over five years, Net Margin peaked at 90.14% in Q4 2023 and troughed at 37.56% in Q1 2023.
• A 5-year average of 5.61% and a median of 11.76% in 2025 frame the typical range for Net Margin.
• Annual changes were most pronounced in 2023 — Net Margin soared 10069 bps — and 2024, when it sank 10792 bps.
• Tracing OFIX's Net Margin over 5 years: stood at 10.55% in 2022, then surged by 955 bps to 90.14% in 2023, then sank by 120 bps to 17.78% in 2024, then surged by 333 bps to 41.4% in 2025, then plunged by 127 bps to 11.23% in 2026.
• Business Quant data shows OFIX's Net Margin at 11.23% in Q1 2026, 41.4% in Q4 2025, and 11.76% in Q3 2025.